Stocktoria
Pulmonx Corp LUNG
Pulmonx Corp financials (annual)
Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $90.5M | $83.8M | $68.7M | $53.7M | $48.4M | $32.7M | $32.6M |
| Gross profit | $67.1M | $62.0M | $50.8M | $39.9M | $35.6M | $21.2M | $22.4M |
| R&D expense | $19.5M | $17.6M | $18.1M | $15.4M | $13.1M | $7.5M | $6.0M |
| SG&A expense | $101.3M | $102.1M | $94.6M | $83.1M | $69.9M | $46.1M | $34.2M |
| Operating income | -$53.7M | -$57.7M | -$61.9M | -$58.6M | -$47.3M | -$32.3M | -$17.8M |
| Interest expense | — | — | $3.2M | $1.1M | $829,000 | $3.2M | $2.3M |
| Income tax | $626,000 | $500,000 | $571,000 | $353,000 | $343,000 | $213,000 | $363,000 |
| Net income | -$54.0M | -$56.4M | -$60.8M | -$58.9M | -$48.7M | -$32.2M | -$20.7M |
| EPS (diluted) | $-1.33 | $-1.44 | $-1.60 | $-1.59 | $-1.35 | $-3.16 | — |
| Operating cash flow | -$32.4M | -$31.5M | -$37.6M | -$45.1M | -$41.4M | -$30.6M | -$20.8M |
| Free cash flow | -$32.8M | -$33.0M | -$38.4M | -$46.4M | -$45.1M | -$31.5M | -$21.5M |
| Cash & equivalents | $69.8M | $70.9M | $83.5M | $101.7M | $148.5M | $231.6M | $14.8M |
| Inventory | $15.8M | $16.9M | $16.7M | $14.6M | $16.3M | $10.7M | $5.6M |
| Total assets | $129.3M | $162.8M | $177.8M | $193.7M | $235.2M | $263.7M | $53.5M |
| Total liabilities | $75.2M | $77.0M | $59.5M | $39.7M | $41.9M | $37.6M | $35.6M |
| Shareholders' equity | $54.1M | $85.8M | $118.3M | $154.0M | $193.2M | $226.1M | -$187.4M |
Growth · year-over-year · Revenue CAGR 18.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue growth | +8.0% | +22.0% | +28.0% | +10.8% | +47.9% | +0.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.